To better meet the needs of our customers, we offer personalized shipping plans that work with production needs
Dihexa for Baby Brain & Postpartum Brain Fog Why baby brain is real: the Davies 2018 Medical Journal of Australia meta-analysis, the Hoekzema 2017 and Pritschet 2024 Nature Neuroscience maternal-brain remodelling studies, the postpartum estradiol-BDNF crash, the allopregnanolone / brexanolone / zuranolone (Zurzuvae, FDA Aug 2023) neurosteroid story, the dominant sleep, postpartum-thyroiditis and iron drivers, ONS 567,708 England births (2024) and the RCPsych July 2025 postnatal-depression estimate and why pregnancy and breastfeeding are absolute contraindications for an unlicensed HGF/c-Met peptide
4 Plus, in rat models of colocutaneous, gastrocutaneous, and rectovaginal fistulas, BPC-157 successfully closed the skin defect and the internal organ defect
Conventional endocrinologists often focus on TSH levels (from your pituitary gland) and perhaps free T4 levels, but thats not close to enough to get the full picture of your diagnosis
A spinoff company, Athira Pharma (formalized as M3 Biotechnology before rebranding), was founded in 2011 by PhD student Leen Kawas to commercialize dihexa and a related molecule, ATH-1017 (fosgonimeton)